MACRONorway's July industrial production falls 7.1% month-over-monthSep 7, 2026
EARNINGSCaleres (CAL) yield and income math ahead of Q2 earnings on Sept. 9Sep 7, 2026
$ETHHarmony proposes full Layer 1 shutdown in pivot to Ethereum and AI videoSep 7, 2026
NIKINiki BioSolutions installs post-merger C-suite with $320,000 COO base and 800,000-share option grantSep 6, 2026
$BTCDollar's 97% purchasing-power loss in 113 years sharpens the Bitcoin store-of-value caseSep 6, 2026
NFLXRoughly 4,000 U.S. data centers power apps, streaming, AI, and moreSep 6, 2026
$BTCMicroStrategy's $250 Bitcoin Jordans Ship Without a Bitcoin CheckoutSep 6, 2026
ENERGYSondland calls for "Godfather Test" to flip Russia attribution burdenSep 6, 2026
MACRONorway's July industrial production falls 7.1% month-over-monthSep 7, 2026
EARNINGSCaleres (CAL) yield and income math ahead of Q2 earnings on Sept. 9Sep 7, 2026
$ETHHarmony proposes full Layer 1 shutdown in pivot to Ethereum and AI videoSep 7, 2026
NIKINiki BioSolutions installs post-merger C-suite with $320,000 COO base and 800,000-share option grantSep 6, 2026
$BTCDollar's 97% purchasing-power loss in 113 years sharpens the Bitcoin store-of-value caseSep 6, 2026
NFLXRoughly 4,000 U.S. data centers power apps, streaming, AI, and moreSep 6, 2026
$BTCMicroStrategy's $250 Bitcoin Jordans Ship Without a Bitcoin CheckoutSep 6, 2026
ENERGYSondland calls for "Godfather Test" to flip Russia attribution burdenSep 6, 2026

Neumora clears toxicology repeat in 162-animal rat study, targets NMRA-215 IND filing for Q4 2026

Zero unexpected in-life adverse findings across 162 rats in a repeat 13-week study removes the primary obstacle for NMRA-215, Neumora Therapeutics' (Nasdaq: NMRA) oral NLRP3 inhibitor targeting obesity and cardiometabolic disease. The…

By Warren Ashby·Jul 27, 2026·2 min read·regulatory·NMRA
Share
Source: sec.gov
© 2026 NewsMeter